The role of haemostasis in placenta-mediated complications

Butler, 1950, S. Gra ff, The relationship of disorders of the blood-clotting mechanism to toxemia of pregnancy and the value of heparin in therapy, Am. J. Obstet. Gynecol., 60, 564, 10.1016/0002-9378(50)90428-5 Van Wijk, 2002, Enhanced coagulation activation in preeclampsia: the role of APC resistance, microparticles and other plasma constituents, Thromb. Haemost., 88, 415, 10.1055/s-0037-1613231 Hamad, 2009, Increased thrombin generation in women with a history of preeclampsia, Thromb. Res., 123, 580, 10.1016/j.thromres.2008.03.022 Erez, 2008, Over-expression of the thrombin receptor (PAR- 1) in the placenta in preeclampsia: a mechanism for the intersection of coagulation and inflammation, J. Matern. Fetal Neonatal Med., 21, 345, 10.1080/14767050802034859 Huang, 2015, Activation of PAR-1/NADPH oxidase/ROS signaling pathways is crucial for the thrombin-induced sFlt-1 production in extravil- lous trophoblasts: possible involvement in the pathogenesis of preeclampsia, Cell Physiol. Biochem., 35, 1654, 10.1159/000373979 Redman, 2005, Latest advances in understanding preeclampsia, Science, 308, 1592, 10.1126/science.1111726 Valensise, 2008, Early and late preeclampsia: two different maternal hemodynamic states in the latent phase of the disease, Hypertension, 52, 873, 10.1161/HYPERTENSIONAHA.108.117358 Egbor, 2006, Morphometric placental villous and vascular abnormalities in early- and late-onset pre-eclampsia with and without fetal growth restriction, BJOG., 113, 580, 10.1111/j.1471-0528.2006.00882.x Staff, 2013, Redefining preeclampsia using placenta-derived biomarkers, Hypertension, 61, 932, 10.1161/HYPERTENSIONAHA.111.00250 Hutt, 1994, Increased platelet volume and aggregation precede the onset of preeclampsia, Obstet. Gynecol., 83, 146 Janes, 1995, Flow cytometric detection of activated platelets in pregnant women prior to the development of pre-eclampsia, Thromb. Haemost., 74, 1059, 10.1055/s-0038-1649882 Sato, 2005, Platelet-derived soluble factors induce human extravillous trophoblast migration and differentiation: platelets are a possible regulator of trophoblast infiltration into maternal spiral arteries, Blood, 106, 428, 10.1182/blood-2005-02-0491 Sood, 2007, Fetal gene defects precipitate platelet- mediated pregnancy failure in factor V Leiden mothers, J. Exp. Med., 204, 1049, 10.1084/jem.20062566 Macey, 2010, Platelet activation and endogenous thrombin potential in pre-eclampsia, Thromb. Res., 125, e76, 10.1016/j.thromres.2009.09.013 Major, 2014, Synthesis of sFlt-1 by platelet-monocyte aggregates contributes to the pathogenesis of preeclampsia, Am. J. Obstet. Gynecol., 210, 547.e1, 10.1016/j.ajog.2014.01.024 Roberge, 2018, Aspirin for the prevention of preterm and term preeclampsia: systematic review and metaanalysis, Am. J. Obstet. Gynecol., 218, 287, 10.1016/j.ajog.2017.11.561 Knight, 1998, Shedding of syncytiotrophoblast microvilli into the maternal circulation in pre-eclamptic pregnancies, Br. J. Obstet. Gynaecol., 105, 632, 10.1111/j.1471-0528.1998.tb10178.x Tannetta, 2015, Syncytiotrophoblast extracellular vesicles from pre-eclampsia placentas differentially affect platelet function, PLoS. One, 10, 10.1371/journal.pone.0142538 Shomer, 2013, Microvesicles of women with gestational hypertension and preeclampsia affect human trophoblast fate and endothelial function, Hypertension, 62, 893, 10.1161/HYPERTENSIONAHA.113.01494 Shomer, 2016, Microvesicles of pregnant women receiving low molecular weight heparin improve trophoblast function, Thromb. Res., 137, 141, 10.1016/j.thromres.2015.11.026 Kohli, 2016, Maternal extracellular vesicles and platelets promote preeclampsia via inflammasome activation in trophoblasts, Blood, 128, 2153, 10.1182/blood-2016-03-705434 Tong, 2017, Micro- and nano-vesicles from first trimester human placentae carry Flt-1 and levels are increased in severe preeclampsia, Front. Endocrinol. (Lausanne), 8, 174, 10.3389/fendo.2017.00174 Cronqvist, 2017, Syncytiotrophoblast derived extracellular vesicles transfer functional placental miRNAs to primary human endothelial cells, Sci. Rep., 7, 4558, 10.1038/s41598-017-04468-0 Gupta, 2006, Occurrence of neutrophil extracellular DNA traps (NETs) in pre-eclampsia: a link with elevated levels of cell-free DNA?, Ann. N. Y. Acad. Sci., 1075, 118, 10.1196/annals.1368.015 Isermann, 2003, The thrombomodulin-protein C system is essential for the maintenance of pregnancy, Nat. Med., 9, 331, 10.1038/nm825 Ebina, 2015, Low levels of palsmaptotein S, protein C and factor XII during early pregnancy and adverse pregnancy outcomes, Thromb. Haemost., 114, 65, 10.1160/TH14-11-0928 Tchaikovski, 2011, Role of protein S and tissue factor pathway inhibitor in the development of activated protein C resistance early in pregnancy in women with a history of preeclampsia, Thromb. Haemost., 106, 914, 10.1160/TH11-04-0244 Minhas, 2017, Activated protein C binds directly to Tie2: possible beneficial effects on endothelial barrier function, Cell Mol. Life Sci., 74, 1895, 10.1007/s00018-016-2440-6 Sood, 2006, Fetomaternal cross talk in the placental vascular bed: control of coagulation by trophoblast cells, Blood, 107, 3173, 10.1182/blood-2005-10-4111 Sood, 2008, Maternal Par4 and platelets contribute to defective placenta formation in mouse embryos lacking thrombomodulin, Blood, 112, 585, 10.1182/blood-2007-09-111302 Zhou, 1997, Preeclampsia is associated with failure of human cytotrophoblasts to mimic a vascular adhesion phenotype. One cause of defective endovascular invasion in this syndrome?, J. Clin. Invest., 99, 2152, 10.1172/JCI119388 Di Paolo, 2003, Increased placental expression of tissue factor is associated with abnormal uterine and umbilical Doppler waveforms in severe preeclampsia with fetal growth restriction, J. Nephrol., 16, 650 Teng, 2010, The relationship between plasma and placental tissue factor, and tissue factor pathway inhibitors in severe pre-eclampsia patients, Thromb. Res., 126, e41, 10.1016/j.thromres.2010.02.012 Ittel, 2011, Increased risk of gestational vascular complications in women with low free tissue factor pathway inhibitor plasma levels out of pregnancy, Thromb. Haemost., 105, 66, 10.1160/TH10-06-0399 Gardiner, 2011, Syncytiotrophoblast microvesicles released from pre-eclampsia placentae exhibit increased tissue factor activity, PLoS. One, 6, 10.1371/journal.pone.0026313 Huang, 2015, Activation of PAR-1/NADPH oxidase/ROS signaling pathways is crucial for the thrombin-induced sFlt-1 production in extra- villous trophoblasts: possible involvement in the pathogenesis of preeclampsia, Cell Physiol. Biochem., 35, 1654, 10.1159/000373979 de B Pinheiro, 2012, D-dimer in preeclampsia: systematic review and meta-analysis, Clin. Chim. Acta., 414, 166, 10.1016/j.cca.2012.08.003 Rajakumar, 2004, Evidence for the functional activity of hypoxia-inducible transcription factors overexpressed in preeclamptic placentae, Placenta, 25, 763, 10.1016/j.placenta.2004.02.011 Hu, 2018, High-mobility group box 1 from hypoxic trophoblasts promotes endothelial microparticle production and thrombophilia in preeclampsia, Arterioscler. Thromb. Vasc. Biol., 38, 1381, 10.1161/ATVBAHA.118.310940